AU2014326975B2 - Multiaptamer target detection - Google Patents

Multiaptamer target detection Download PDF

Info

Publication number
AU2014326975B2
AU2014326975B2 AU2014326975A AU2014326975A AU2014326975B2 AU 2014326975 B2 AU2014326975 B2 AU 2014326975B2 AU 2014326975 A AU2014326975 A AU 2014326975A AU 2014326975 A AU2014326975 A AU 2014326975A AU 2014326975 B2 AU2014326975 B2 AU 2014326975B2
Authority
AU
Australia
Prior art keywords
aptamer
target
deoxyuridine
complex
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014326975A
Other languages
English (en)
Other versions
AU2014326975A2 (en
AU2014326975A1 (en
Inventor
Larry Gold
Louis S. GREEN
Nebojsa Janjic
Urs A. OCHSNER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somalogic Operating Co Inc
Original Assignee
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Operating Co Inc filed Critical Somalogic Operating Co Inc
Publication of AU2014326975A1 publication Critical patent/AU2014326975A1/en
Publication of AU2014326975A2 publication Critical patent/AU2014326975A2/en
Application granted granted Critical
Publication of AU2014326975B2 publication Critical patent/AU2014326975B2/en
Assigned to SOMALOGIC OPERATING CO., INC. reassignment SOMALOGIC OPERATING CO., INC. Request for Assignment Assignors: SOMALOGIC, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1048—SELEX
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/13—Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/205—Aptamer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2014326975A 2013-09-24 2014-09-24 Multiaptamer target detection Active AU2014326975B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361881629P 2013-09-24 2013-09-24
US61/881,629 2013-09-24
PCT/US2014/057143 WO2015048084A1 (en) 2013-09-24 2014-09-24 Multiaptamer target detection

Publications (3)

Publication Number Publication Date
AU2014326975A1 AU2014326975A1 (en) 2016-04-07
AU2014326975A2 AU2014326975A2 (en) 2017-01-05
AU2014326975B2 true AU2014326975B2 (en) 2020-05-07

Family

ID=52744404

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014326975A Active AU2014326975B2 (en) 2013-09-24 2014-09-24 Multiaptamer target detection

Country Status (13)

Country Link
US (2) US9926566B2 (cg-RX-API-DMAC7.html)
EP (1) EP3049523B1 (cg-RX-API-DMAC7.html)
JP (1) JP6506768B2 (cg-RX-API-DMAC7.html)
KR (1) KR102348283B1 (cg-RX-API-DMAC7.html)
CN (2) CN105555957A (cg-RX-API-DMAC7.html)
AU (1) AU2014326975B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016005957A2 (cg-RX-API-DMAC7.html)
CA (1) CA2924987C (cg-RX-API-DMAC7.html)
HK (1) HK1218765A1 (cg-RX-API-DMAC7.html)
IL (1) IL244284B (cg-RX-API-DMAC7.html)
MX (1) MX361451B (cg-RX-API-DMAC7.html)
SG (1) SG11201602063UA (cg-RX-API-DMAC7.html)
WO (1) WO2015048084A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX361451B (es) 2013-09-24 2018-12-06 Somalogic Inc Detección objetivo de múltiples aptámeros.
RU2708170C2 (ru) 2014-11-24 2019-12-04 Сомалоджик, Инк. Соединения нуклеиновой кислоты для связывания ростового фактора дифференцировки 11
WO2017100441A1 (en) * 2015-12-08 2017-06-15 Twinstrand Biosciences, Inc. Improved adapters, methods, and compositions for duplex sequencing
TWI733772B (zh) 2016-03-14 2021-07-21 美商身體邏輯股份有限公司 用於合成吲哚環核鹼基結合物之組成物及方法
WO2017218881A1 (en) * 2016-06-17 2017-12-21 Proximity Biosciences, Llc Method for aptamer pair selection
US10927380B2 (en) * 2016-07-01 2021-02-23 Somalogic, Inc. Oligonucleotides comprising modified nucleosides
JP2020514746A (ja) 2016-12-01 2020-05-21 ノーティラス バイオテクノロジー インコーポレイテッド タンパク質をアッセイする方法
WO2019103131A1 (ja) * 2017-11-24 2019-05-31 国立大学法人 東京大学 アプタマーの結合部位判別方法、アプタマーペアおよび目的物質からなる三元錯体の解離定数等の測定方法並びに最適なアプタマーペアの選択方法
CA3086915A1 (en) 2017-12-29 2019-07-04 Sujal M. Patel Decoding approaches for protein identification
US20210247387A1 (en) * 2018-06-22 2021-08-12 Somalogic, Inc. Improved proteomic multiplex assays
CA3182266A1 (en) 2020-06-11 2021-12-16 Vadim Lobanov Methods and systems for computational decoding of biological, chemical, and physical entities
CA3203106A1 (en) 2021-01-20 2022-07-28 Parag Mallick Systems and methods for biomolecule quantitation
US20220227890A1 (en) 2021-01-21 2022-07-21 Nautilus Biotechnology, Inc. Systems and methods for biomolecule preparation
IL305336B2 (en) 2021-03-11 2025-09-01 Nautilus Subsidiary Inc Systems and methods for preserving biomolecules
EP4399528A1 (en) 2021-09-09 2024-07-17 Nautilus Subsidiary, Inc. Characterization and localization of protein modifications
EP4405683A1 (en) 2021-09-22 2024-07-31 Nautilus Subsidiary, Inc. Methods and systems for determining polypeptide interactions
WO2023081728A1 (en) 2021-11-03 2023-05-11 Nautilus Biotechnology, Inc. Systems and methods for surface structuring
EP4441503A1 (en) 2021-11-30 2024-10-09 Nautilus Subsidiary, Inc. Particle-based isolation of proteins and other analytes
CA3245990A1 (en) 2022-03-29 2023-10-05 Nautilus Subsidiary, Inc. INTEGRATED NETWORKS FOR SINGLE-ANALYTE PROCESSES
EP4515026A1 (en) 2022-04-25 2025-03-05 Nautilus Subsidiary, Inc. Systems and methods for assessing and improving the quality of multiplex molecular assays
WO2023250364A1 (en) 2022-06-21 2023-12-28 Nautilus Subsidiary, Inc. Method for detecting analytes at sites of optically non-resolvable distances
WO2024059655A1 (en) 2022-09-15 2024-03-21 Nautilus Subsidiary, Inc. Characterizing accessibility of macromolecule structures
WO2024073599A1 (en) 2022-09-29 2024-04-04 Nautilus Subsidiary, Inc. Preparation of array surfaces for single-analyte processes
US20240183858A1 (en) 2022-11-15 2024-06-06 Nautilus Subsidiary, Inc. Standard polypeptides
US20240192202A1 (en) 2022-12-09 2024-06-13 Nautilus Subsidiary, Inc. Fluidic media for single-analtye arrays
EP4634285A1 (en) 2022-12-15 2025-10-22 Nautilus Subsidiary, Inc. Inhibition of photon phenomena on single molecule arrays
US20240241110A1 (en) 2023-01-12 2024-07-18 Nautilus Subsidiary, Inc. Characterization of glycans and glycoconjugates
EP4689173A1 (en) 2023-03-24 2026-02-11 Nautilus Subsidiary, Inc. Improved transfer of nanoparticles to array surfaces
WO2024216233A1 (en) 2023-04-13 2024-10-17 Nautilus Subsidiary, Inc. Artificial proteins for displaying epitopes
US20240394902A1 (en) 2023-05-24 2024-11-28 Nautilus Subsidiary, Inc. Systems and methods for machine vision
US20250189519A1 (en) 2023-12-11 2025-06-12 Nautilus Subsidiary, Inc. Methods and compositions of particle-based arrays
US20250205706A1 (en) 2023-12-20 2025-06-26 Nautilus Subsidiary, Inc. Fluidic devices for single-analyte assays
US20250298016A1 (en) 2024-03-22 2025-09-25 Nautilus Subsidiary, Inc. Plasmonic particle systems for single-analyte assays
US20250305034A1 (en) 2024-04-01 2025-10-02 Nautilus Subsidiary, Inc. Nanostructures for modulation of analyte conformation
WO2026073213A1 (en) * 2024-09-30 2026-04-02 Illumina, Inc. Protein capture techniques with surface linked aptamers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120231467A1 (en) * 2011-03-10 2012-09-13 Somalogic, Inc. Aptamers for C. Difficile Diagnostics

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001257091A1 (en) * 2000-04-18 2001-10-30 Gilead Sciences, Inc. Aptamer based two-site binding assay
WO2002026932A2 (en) * 2000-09-26 2002-04-04 Duke University Rna aptamers and methods for identifying the same
US20070071744A1 (en) * 2002-06-07 2007-03-29 Gotz Munch Agents which bind to epitopes of glycoprotein VI
US7595160B2 (en) 2004-01-13 2009-09-29 U.S. Genomics, Inc. Analyte detection using barcoded polymers
US7795009B2 (en) * 2005-06-15 2010-09-14 Saint Louis University Three-component biosensors for detecting macromolecules and other analytes
US20100035247A1 (en) 2005-11-04 2010-02-11 U.S. Genomics, Inc. Heterogeneous Assay of Analytes in Solution Using Polymers
US8658670B2 (en) 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
ES3045958T3 (en) * 2007-07-17 2025-12-01 Somalogic Operating Co Inc Method for generating aptamers with improved off-rates
US20100239682A1 (en) 2007-09-17 2010-09-23 Antoine Andremont Colonic delivery of antimicrobial agents
US8569252B2 (en) 2009-04-15 2013-10-29 Postech Academy-Industry Foundation Nucleolin specific aptamer and use thereof
US20110256535A1 (en) 2010-02-11 2011-10-20 Intelligent Medical Devices, Inc. Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantification, monitoring, screening and sequencing of clostridium difficile genes encoding toxin b, and/or toxin a and/or binary toxin
GB201002627D0 (en) 2010-02-16 2010-03-31 Loxbridge Res Llp Aptamer based analyte detection method
NZ602618A (en) * 2010-04-12 2013-12-20 Somalogic Inc Aptamers to beta-ngf and their use in treating beta-ngf mediated diseases and disorders
US8785132B2 (en) * 2010-04-23 2014-07-22 Postech Academy-Industry Foundation Aptamer sandwich assays
US20150031585A1 (en) 2011-03-10 2015-01-29 Somalogic, Inc. Multiaptamer Target Detection
AU2012249658A1 (en) * 2011-04-26 2013-05-09 Regado Biosciences, Inc. A method for manufacturing pegylated oligonucleotides
KR102248900B1 (ko) 2011-09-30 2021-05-07 소마로직, 인크. 심혈관 위험 사건 예측 및 그것의 용도
MX355567B (es) 2011-12-30 2018-04-23 Quest Diagnostics Invest Inc Aptameros y metodos de diagnostico para detectar el receptor de egf.
MX361451B (es) 2013-09-24 2018-12-06 Somalogic Inc Detección objetivo de múltiples aptámeros.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120231467A1 (en) * 2011-03-10 2012-09-13 Somalogic, Inc. Aptamers for C. Difficile Diagnostics

Also Published As

Publication number Publication date
EP3049523A4 (en) 2017-05-17
MX361451B (es) 2018-12-06
CN105555957A (zh) 2016-05-04
JP2016531593A (ja) 2016-10-13
AU2014326975A2 (en) 2017-01-05
AU2014326975A1 (en) 2016-04-07
KR102348283B1 (ko) 2022-01-10
WO2015048084A1 (en) 2015-04-02
CA2924987C (en) 2022-08-16
SG11201602063UA (en) 2016-04-28
IL244284A0 (en) 2016-04-21
KR20160058777A (ko) 2016-05-25
US9926566B2 (en) 2018-03-27
JP6506768B2 (ja) 2019-04-24
HK1218765A1 (zh) 2017-03-10
US10392621B2 (en) 2019-08-27
CA2924987A1 (en) 2015-04-02
BR112016005957A2 (pt) 2017-09-26
EP3049523B1 (en) 2019-08-07
CN114703193A (zh) 2022-07-05
MX2016003320A (es) 2016-05-31
EP3049523A1 (en) 2016-08-03
US20180187197A1 (en) 2018-07-05
IL244284B (en) 2019-12-31
US20160237435A1 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
US10392621B2 (en) Multiaptamer target detection
US12180482B2 (en) Oligonucleotides comprising modified nucleosides
JP6018096B2 (ja) クロストリジウム・ディフィシレ診断法のためのアプタマー
US20150031585A1 (en) Multiaptamer Target Detection
Class et al. Patent application title: Multiaptamer Target Detection Inventors: Urs A. Ochsner (Denver, CO, US) Louis S. Green (Lafayette, CO, US) Larry Gold (Boulder, CO, US) Nebojsa Janjic (Boulder, CO, US) Nebojsa Janjic (Boulder, CO, US) Evaldas Katilius (Superior, AZ, US)
HK1227430B (en) Multiaptamer target detection
HK1227430A1 (en) Multiaptamer target detection
CA3027626C (en) Oligonucleotides comprising modified nucleosides
HK40121627A (en) Oligonucleotides comprising modified nucleosides
HK40055415A (en) Oligonucleotides comprising modified nucleosides
HK40003636B (en) Oligonucleotides comprising modified nucleosides
BR112018075869B1 (pt) Aptâmeros, suas composições e métodos para identificar um ou mais aptâmeros capazes de se ligar a uma molécula alvo e para detectar um alvo em uma amostra utilizando os mesmos
HK40003636A (en) Oligonucleotides comprising modified nucleosides
NZ749251A (en) Oligonucleotides comprising modified nucleosides

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 13 DEC 2016

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: SOMALOGIC OPERATING CO., INC.

Free format text: FORMER OWNER(S): SOMALOGIC, INC.